IPA Develops AI-Designed GLP-1 Therapies
ImmunoPrecise Antibodies utilizes AI to create novel GLP-1 therapies aimed at enhancing diabetes treatment efficacy, safety, and patient satisfaction.
Read More
Year: 2025
Microsoft and OpenAI Strengthen AI Partnership
Microsoft and OpenAI extend their strategic partnership to enhance AI development through IP rights, revenue sharing, and increased investment, solidifying Azure’s exclusivity for OpenAI APIs.
Read More
Staff Seek AI Upskilling Amid Training Gaps
Despite 80% of Irish employees wanting to upskill in AI, only 16% have received training. A significant gap exists between interest and employer support.
Read More